Gilead Sciences and Unite for HER Launch Program to Support Metastatic Breast Cancer Patients
Gilead Sciences partners with Unite for HER to offer free integrative care to Black, Hispanic, and underserved metastatic breast cancer patients in the U.S., enhancing treatment adherence and quality of life.
Gilead Sciences, Inc. has partnered with Unite for HER (UFH) to introduce the Metastatic Breast Cancer Sustainer Program, a free integrative care initiative aimed at Black, Hispanic, and underserved metastatic breast cancer patients across the United States. This program offers a range of services including acupuncture, counseling, nutrition support, and fitness memberships, all at no cost to the patient.
Sue Weldon, Founder and CEO of Unite for HER, highlighted the program's impact, noting its role in providing dignity, equity, and whole-person care to its members. Since its inception in October 2023, the program has already supported over 2,823 patients, with Gilead Sciences' funding enabling a focused initiative for Black, Hispanic, and underserved communities.
Carmen Villar, Senior Vice President of Global Giving, Advocacy, and Responsibility at Gilead Sciences, emphasized the company's commitment to addressing the unique needs of the metastatic breast cancer community through innovative solutions. This partnership underscores Gilead's dedication to making a measurable difference in the lives of those affected by cancer.
For more information on the program and Unite for HER's services, visit https://www.uniteforher.org.